A record of what Ramesh Damani said publicly, with the source. Not advice.
Pending — not yet graded
“The pharma sector offers opportunities, particularly in Indian companies developing intellectual property, such as CDMO firms. These companies are temporarily exempted from tariffs, providing a favorable environment for growth within the broader domestic-focused investment theme.”
Nifty PharmaBullishCalled 04 Apr 2025
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.
Read the original articleSee Ramesh Damani’s full track record